sk&f-38393 has been researched along with Anochlesia in 20 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Excerpt | Relevance | Reference |
|---|---|---|
| "By contrast, catalepsy induced by a single injection of haloperidol lasted only approximately 2 days, and tolerance developed to its effects after long-term treatment." | 1.30 | D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. ( Davidkova, G; Morabito, M; Weiss, B; Zhang, SP; Zhou, LW, 1998) |
| "This "injection-conditioned catalepsy" was also observed after repeated treatment with the dopamine D2 antagonists, haloperidol and metoclopramide." | 1.30 | Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice. ( Chinen, CC; Frussa-Filho, R, 1999) |
| "Therefore, the THC-induced catalepsy model may be useful for distinguishing between both classes of NMDA receptor antagonists." | 1.29 | Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice. ( Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I, 1994) |
| "1." | 1.28 | Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice. ( Habibi-Moini, S; Zarrindast, MR, 1991) |
| "SCH 23390-induced catalepsy was potentiated by a large dose of the D-2 agonist, bromocriptine." | 1.27 | D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways. ( Block, H; Klemm, WR, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 11 (55.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowak, P | 2 |
| Dabrowska, J | 1 |
| Bortel, A | 1 |
| Biedka, I | 1 |
| Szczerbak, G | 1 |
| Słomian, G | 1 |
| Kostrzewa, RM | 2 |
| Brus, R | 2 |
| Arnt, J | 2 |
| Hyttel, J | 1 |
| Rodríguez de Fonseca, F | 1 |
| Martín Calderón, JL | 1 |
| Mechoulam, R | 1 |
| Navarro, M | 1 |
| Kinoshita, H | 1 |
| Hasegawa, T | 1 |
| Kameyama, T | 1 |
| Yamamoto, I | 1 |
| Nabeshima, T | 1 |
| Rosenzweig-Lipson, S | 1 |
| Bergman, J | 2 |
| Bartoszyk, GD | 1 |
| Harting, J | 1 |
| Minck, KO | 1 |
| Marin, C | 1 |
| Engber, TM | 1 |
| Chaudhuri, P | 1 |
| Peppe, A | 1 |
| Chase, TN | 1 |
| Szkilnik, R | 1 |
| Tidey, JW | 1 |
| Davidkova, G | 1 |
| Zhou, LW | 1 |
| Morabito, M | 1 |
| Zhang, SP | 1 |
| Weiss, B | 1 |
| Chinen, CC | 1 |
| Frussa-Filho, R | 1 |
| Platt, DM | 1 |
| Rowlett, JK | 1 |
| Spealman, RD | 1 |
| Meyer, ME | 1 |
| Cottrell, GA | 1 |
| Van Hartesveldt, C | 1 |
| Zarrindast, MR | 1 |
| Habibi-Moini, S | 1 |
| Andersen, PH | 1 |
| Nielsen, EB | 1 |
| Scheel-Krüger, J | 1 |
| Jansen, JA | 1 |
| Hohlweg, R | 1 |
| Ogren, SO | 1 |
| Fuxe, K | 1 |
| Puglisi-Allegra, S | 1 |
| Cabib, S | 1 |
| Hess, EJ | 1 |
| Albers, LJ | 1 |
| Le, H | 1 |
| Creese, I | 1 |
| Klemm, WR | 1 |
| Block, H | 1 |
20 other studies available for sk&f-38393 and Anochlesia
| Article | Year |
|---|---|
Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Benzazepines; | 2006 |
Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Antipsychotic Agen | 1984 |
Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Catalepsy; Dopamine Agents; Dro | 1994 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; | 1994 |
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, | 1994 |
Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Avoidance Learning | 1996 |
Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidin | 1996 |
Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Catalepsy; Do | 1997 |
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines | 1998 |
D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; | 1998 |
Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; | 1999 |
Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Cocain | 2000 |
Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; | 1992 |
Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Dopami | 1991 |
Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; | 1985 |
Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepi | 1987 |
D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Corpus | 1988 |
The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepi | 1988 |
Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Behavior, An | 1986 |
D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Brom | 1988 |